QHSLab, Inc. Files 8-K: Material Agreement & Equity Sales
Ticker: USAQ · Form: 8-K · Filed: Oct 22, 2024 · CIK: 856984
Sentiment: neutral
Topics: material-agreement, equity-sale, disclosure
TL;DR
QHSLab (QHS) signed a big deal and sold stock on 10/18. Watch for dilution.
AI Summary
On October 18, 2024, QHSLab, Inc. entered into a material definitive agreement. The company also disclosed unregistered sales of equity securities and provided a Regulation FD disclosure. The filing includes financial statements and exhibits.
Why It Matters
This 8-K filing indicates significant corporate activity for QHSLab, Inc., including a new material agreement and potential dilution from equity sales, which could impact investors.
Risk Assessment
Risk Level: medium — The filing mentions a material definitive agreement and unregistered sales of equity securities, which can introduce financial and ownership risks.
Key Players & Entities
- QHSLab, Inc. (company) — Registrant
- October 18, 2024 (date) — Date of earliest event reported
- Nevada (state) — State of Incorporation
FAQ
What is the nature of the material definitive agreement entered into by QHSLab, Inc. on October 18, 2024?
The filing states that QHSLab, Inc. entered into a material definitive agreement on October 18, 2024, but the specific details of this agreement are not provided in the provided text.
What type of equity securities were sold by QHSLab, Inc. under unregistered sales?
The filing mentions unregistered sales of equity securities, but the specific type and amount of securities sold are not detailed in the provided text.
What is the purpose of the Regulation FD disclosure included in this 8-K filing?
The filing indicates a Regulation FD disclosure was made, which is typically to ensure broad public dissemination of material information, but the specific content of the disclosure is not detailed here.
What financial statements and exhibits are included with this 8-K filing?
The filing lists 'Financial Statements and Exhibits' as an item, but the specific content of these financial statements and exhibits is not described in the provided text.
What was QHSLab, Inc.'s former name and when did the name change occur?
QHSLab, Inc. was formerly known as USA EQUITIES CORP. until November 19, 2015, and prior to that, USA EQUITY CORP. until November 16, 2015, and AMERICAN BIOGENETIC SCIENCES INC until April 26, 1994.
Filing Stats: 764 words · 3 min read · ~3 pages · Grade level 9.5 · Accepted 2024-10-22 08:30:29
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value USAQ N/A Item 1.01 Entr
Filing Documents
- form8-k.htm (8-K) — 42KB
- ex10-1.htm (EX-10.1) — 6KB
- ex10-1_001.jpg (GRAPHIC) — 1452KB
- ex10-1_002.jpg (GRAPHIC) — 1464KB
- ex10-1_003.jpg (GRAPHIC) — 1583KB
- ex10-1_004.jpg (GRAPHIC) — 726KB
- ex10-1_005.jpg (GRAPHIC) — 233KB
- ex10-1_006.jpg (GRAPHIC) — 1120KB
- ex10-1_007.jpg (GRAPHIC) — 760KB
- ex99-1.htm (EX-99.1) — 18KB
- ex99-1_001.jpg (GRAPHIC) — 8KB
- 0001493152-24-041891.txt ( ) — 10348KB
- usaq-20241018.xsd (EX-101.SCH) — 3KB
- usaq-20241018_lab.xml (EX-101.LAB) — 33KB
- usaq-20241018_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this current report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: October 22, 2024 QHSLab, Inc. /s/ Troy Grogan Name: Troy Grogan Title: CEO and Chairman